Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00835627 · ClinicalTrials.gov registry record · Phase 4
Treatment Trial for Psychogenic Nonepileptic Seizures
A Phase 4 study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 38
- Enrollment target
NCT00835627 is a Phase 4 study that has completed, run by Rhode Island Hospital. The registered enrollment target is 38 participants.
The verdict
NCT00835627, a Phase 4 study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 38 participants
- Enrollment target
Study Summary
The investigators propose that patients who receive targeted pharmacotherapy (sertraline) or focused psychotherapy (cognitive behavioral therapy-informed psychotherapy (CBT-ip) for NES) or combined treatment (CBT-ip + sertraline) will report fewer nonepileptic seizures (NES) compared to patients who receive community care / treatment as usual (TAU). The purpose of this study is to provide pilot testing and data to inform the future multicenter randomized controlled trial based on the hypothesis.
Interventions
- DRUG sertraline
- OTHER Standard Care
- BEHAVIORAL CBT-ip
- OTHER Combined (sertraline + CBT-ip)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00835627
The ClinicalTrials.gov registry entry for NCT00835627 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which sertraline is the first listed.
NCT00835627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00835627 about?
NCT00835627 is a clinical study titled "Treatment Trial for Psychogenic Nonepileptic Seizures". The investigators propose that patients who receive targeted pharmacotherapy (sertraline) or focused psychotherapy (cognitive behavioral therapy-informed psychotherapy (CBT-ip) for NES) or combined treatment (CBT-ip + sertraline) will report fewer nonepileptic seizures (NES) compared to patients who...
What is the current status of trial NCT00835627?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 2008-09. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00835627?
The interventions under investigation include: sertraline (DRUG), Standard Care (OTHER), CBT-ip (BEHAVIORAL), Combined (sertraline + CBT-ip) (OTHER).
Who is sponsoring clinical trial NCT00835627?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.